News

9 March 2026

The role of microbial genomics in delivering the UK’s national action plan for confronting antimicrobial resistance 2024–29

9 March 2026

AI could revolutionize antibiotics — but the market is standing in the way

7 February 2026

PASTEUR Act Reintroduced in Congress

5 February 2026

Ultra-rapid nanoplasmonic colorimetry in microfluidics for antimicrobial susceptibility testing directly from specimens

4 February 2026

The C-CAMP – ICARS One Health AMR Challenge 2025 identifies seven awarded innovations for AMR across the One Health spectrum

2 February 2026

Integrating infodemiology and infodemics management to address antimicrobial resistance and vaccine hesitancy challenges in Nigeria/Africa

2 February 2026

Quantifying the real-world impact of antibiotic use and genetic determinants of resistance on gonococcal dynamics

30 January 2026

Artificial intelligence predicts healthcare workers’ antibiotic use intentions from psychological and behavioral measures across multiple theories

27 January 2026

An overview of global public and philanthropic investments into antibacterial therapeutics (2017–23)

27 January 2026

Measuring Infectious Causes and Resistance Outcomes for Burden Estimation (MICROBE)

27 January 2026

GARDP and Debiopharm Partner to Advance Development of Novel Gonorrhea Drug

26 January 2026

Global AMR R&D Hub and Chinese Academy of Sciences launch strategic partnership to advance antimicrobial resistance research

23 January 2026

Antimicrobial peptides: natural templates for next-generation therapeutics against antimicrobial resistance

23 January 2026

New Global Consortium Aims to Transform Antibiotic Discovery to Counter the Growing AMR Crisis

14 January 2026

Nanomedicines in the treatment of methicillin-resistant Staphylococcus aureus

12 January 2026

Antimicrobial resistance databases: opportunities and challenges for public health

12 January 2026

EMBL–EBI’s AMR portal: a new gateway in global antimicrobial resistance research

9 January 2026

New antimicrobial substances to combat increasing resistance

8 January 2026

Rethinking the unmet need for novel antibiotics

7 January 2026

Artificial intelligence for sustainable solutions in combating antimicrobial resistance through data driven health innovations

18 December 2025

Rapid culture-free diagnosis of clinical pathogens via integrated microfluidic-Raman micro-spectroscopy

18 December 2025

Biased sampling driven by bacterial population structure confounds machine learning prediction of antimicrobial resistance

18 December 2025

Gene copy-number features generalize better than SNPs for antimicrobial resistance prediction in Staphylococcus aureus

12 December 2025

Emerging antimicrobial hydrogel dressings based on bacterial cellulose–chitosan composites: A review

8 December 2025

The AMR Knowledge Space Game: participatory modeling to address the complexity of antimicrobial resistance

3 December 2025

Artificial Intelligence-Integrated Biosensors for Antimicrobial Resistance Detection and Surveillance: A Review and Future Perspectives for Global Biosecurity

28 November 2025

Beyond resistance: alternative innovation models for global access and stewardship of new antibiotics

27 November 2025

The Role of Machine Learning in Addressing Antibiotic Resistance: A New Era in Infectious Disease Control

21 November 2025

GSK and Fleming Initiative scientists unite to target AMR with advanced AI

19 November 2025

A new gateway to global antimicrobial resistance data

17 November 2025

Antibacterial products in clinical development for bacterial priority pathogens

17 November 2025

Antibacterial products in preclinical development for bacterial priority pathogens

11 November 2025

Novel antimicrobial strategy: native postbiotics synergize with antibiotics to overcome resistance in Klebsiella pneumoniae

10 November 2025

Isotype conversion of Staphylococcal-specific IgG into IgM broadens the reactivity to other bacterial pathogens

10 November 2025

Breaking barriers in antimicrobial therapy: resistance mechanisms and novel antimicrobial strategies

7 November 2025

There is urgent need for a Global Data Resource for Antimicrobial PK/PD: CAMO-Net GDR Initiative

5 November 2025

Computational framework for streamlining the success of sequential antibiotic therapy

30 October 2025

The applications and advantages of nanopore sequencing in bacterial antimicrobial resistance surveillance and research

28 October 2025

Phage-antibiotics synergy and nanotechnology interventions in the management of drug resistance among bacterial pathogens: A scoping review

24 October 2025

Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy

24 October 2025

Phenotypic and genotypic characterization of probiotic strains in the context of antimicrobial resistance

24 October 2025

Structural basis for antibiotic resistance by chloramphenicol acetyltransferase type A in Staphylococcus aureus

16 October 2025

Localized and controlled antibiotic therapy via microneedles: A biomedical approach to antimicrobial resistance

10 October 2025

The Emerging Resistance Index: tracking early resistance to new antibiotics

8 October 2025

Winners Announced for the 2025 Vivli AMR Surveillance Data Challenge, funded by Johnson & Johnson, Paratek, Pfizer, and NIH

6 October 2025

Discovery and artificial intelligence-guided mechanistic elucidation of a narrow-spectrum antibiotic

6 October 2025

AMR Drugs and Diagnostics Must Evolve in Tandem

6 October 2025

Analysis of antibacterial agents in clinical and preclinical development: overview and analysis 2025

3 October 2025

Innovative Approaches to Combat Antimicrobial Resistance: A Review of Emerging Therapies and Technologies

30 September 2025

New European Partnership on One Health AMR: €253 million for research and innovation against antimicrobial resistance